
Tevogen Pursues Generics Expansion with Apozeal Acquisition Letter of Intent
Tevogen Bio signs Letter of Intent to acquire Apozeal Pharmaceutical, gaining 11 FDA-approved generics and pipeline assets to expand domestic manufacturing strategy.
TVGNTVGNWacquisitiondomestic supply chain